Chronic Use of β-Blockers and the Risk of Parkinson's Disease.
Gideon KorenGalia NortonKira RadinskyVarda ShalevPublished in: Clinical drug investigation (2019)
Chronic use of β-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. In view of the available alternatives for β-blockers, their chronic use should be carefully reconsidered.